BIS.US ProShares UltraShort Nasdaq Biotechnology

- USD
No recent price
Total assets
1.67M
Expense ratio
0.96%
Dividend yield
5.95%
1-year return
-46.77%
Holdings
104
Since
2010

Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.

What does BIS.US invest in?

  • Mostly Cash (191.3%)
  • Top 3 holdings: 22.6% of the fund

Asset allocation

  • Cash 191.3%
  • Other 100.0%

Top holdings

All holdings, sectors and regions

ProShares UltraShort Nasdaq Biotechnology performance

Sharpe ratio -1.45
This year
-43.98%
1 year
-46.77%
3 years
-39.51%
5 years
-21.38%

Volatility 29.5% over 1 year and 31.0% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

BIS.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About ProShares UltraShort Nasdaq Biotechnology

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund i…

Full fund profile